Global Septic Shock Treatment Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 253

  • Format: PPT, PDF

Global Sepsis and Septic Shock Treatment Market: Segmented by Treatment Type (Antimicrobial Therapy, Adjunctive Therapy) – Growth, Future Prospects & Competitive Analysis, 2019 – 2028

Clear

Report Overview

The global sepsis and septic shock market size stood at around USD 3.5 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Sepsis is a potentially life-threatening complication due to the presence of both infection and the systemic inflammatory response; it is caused by an overwhelming immune response to infection. Sepsis is treated as a medical emergency, and severe cases of sepsis may lead to septic shock, in which blood pressure reduces dramatically. It is estimated that the sepsis and septic shock treatment market will show significant market growth over the forecast period primarily due to the growing number of target population, higher number of unmet needs, advancement in sepsis assessment techniques, and presence of novel pipeline therapeutics

Market Growth Drivers

The most important driver of growth in the sepsis and septic shock marketplace will be the arrival of the first therapies targeting specific segments of the sepsis population

An aging population is one of the dominant factors in the increased incidence rate of sepsis and septic shock during the forecast period

Innovations in R&D strategies and the implementation of adaptive clinical trial designs that feature long-term all-cause mortality outcomes will continue to drive the launch of clinical pipeline drugs throughout the forecast period

Improvements in the management of sepsis and septic shock patients will result in decreased mortality rates and an increased number of patients in need of immunostimulatory or immunosuppressive treatment options to restore immune homeostasis

The launch of Asahi’s thrombomodulin will foster increased participation in the development pipeline of novel sepsis and septic shock therapies

Continued awareness campaigns of sepsis and septic shock at the national and international levels will result in earlier diagnosis and improved outcomes for patients

1. Global Sepsis and Septic Shock Treatment Market Overview…………………….
A. Market Size
2. Market Growth Drivers……………………………………………………..……………………………….
A. Rising Number of Affected Population
B. Strong Presence of Pipeline Drugs
C. Technological Advancement in Sepsis Assessment
3. Epidemiology……………………………………………………………………………………………………….
A. New Prevalent Cases of Sepsis and Septic Shock
B. Diagnosed and Treated cases of Sepsis and Septic Shock
4. Sepsis and Septic Shock Treatment Market Segmentation……………..………
A. By Treatment Type
I. Antimicrobial Therapy
II. Antiviral Drugs
III. Antifungal Drugs
IV. Adjunctive Therapy
B. By Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Latin America, Middle-East and Africa Market Analysis
5. Sepsis and Septic Shock Treatment Major Drugs Market Share………………
A. Market Analysis, Insights and Forecast to 2028 by Revenue
6. Competitive Landscape………………………………………………………….………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………………………………
A. Bristol Myers Squibb Company overview, Product & Services, Strategies & Financials
B. Pfizer Inc. Company overview, Product & Services, Strategies & Financials
C. Adrenomed AG Company Profile, Product & Services, Strategies & Financials
8. Potential Growth Opportunities………………………………………………..……………………..
A. Advancements in drug development
B. Untapped markets in developing economies
9. Factors Driving Future Growth…………………………………………………………………………
A. Key Industry Trends and Recent Developments in Sepsis and Septic Shock Treatment
B. Future Opportunities
10. Conclusion

Market Segmentation

By Treatment Type:

It is expected that the global sepsis and septic shock treatment market will show lucrative market growth majorly due to the rising number of affected population, technological development in sepsis assessment, increase in research and development for developing sepsis treatments, and expected launch of novel pipeline molecules over the forecast period. It is studied that antibacterial drugs among the antimicrobial therapies is the major revenue-generating segment and anticipated to show the fastest market growth during the forecast period. Because bacteria such as Staphylococcus and Escherichia coli are the most common causes of sepsis. Furthermore, the expected launch of pipeline drugs such as MDX 1105, CYT-107, ALT-836, LB-1148, IFX-1 etc. would assist the market growth of sepsis drugs during the forecast period. Broad-spectrum antibiotics are preferably used to initiate treatment as these are effective against a variety of bacteria. Currently, there is no approved regimen specific to the treatment of sepsis but antimicrobials and adjunctive therapies are used to treat and management of sepsis. Previously, activated drotrecogin Alfa (Xigris) was approved for sepsis, but has been voluntarily withdrawn by Eli Lilly in 2011 due to lack of efficacy

By Region:

It is expected that the global sepsis and septic shock treatment market will show lucrative market growth majorly due to the rising number of affected population, technological development in sepsis assessment, increase in research and development for developing sepsis treatments, and expected launch of novel pipeline molecules over the forecast period. It is studied that antibacterial drugs among the antimicrobial therapies is the major revenue-generating segment and anticipated to show the fastest market growth during the forecast period. Because bacteria such as Staphylococcus and Escherichia coli are the most common causes of sepsis. Furthermore, the expected launch of pipeline drugs such as MDX 1105, CYT-107, ALT-836, LB-1148, IFX-1 etc. would assist the market growth of sepsis drugs during the forecast period. Broad-spectrum antibiotics are preferably used to initiate treatment as these are effective against a variety of bacteria. Currently, there is no approved regimen specific to the treatment of sepsis but antimicrobials and adjunctive therapies are used to treat and management of sepsis. Previously, activated drotrecogin Alfa (Xigris) was approved for sepsis, but has been voluntarily withdrawn by Eli Lilly in 2011 due to lack of efficacy

 

Key Industry Players

Currently, there is no specific regimen approved in the market to cure sepsis and septic shock, however antimicrobial drugs and other adjunctive therapies are used according to treatment and management of sepsis. Key players involved in R&D activities are Adrenomed AG, Altor Bioscience Corporation, Asahi Kasei Pharma, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, InflaRx GmbH, Inotrem SA, Pfizer Inc., and others

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements